
Johnson & Johnson considering sale of orthopedics business - report
🇺🇸EARNINGS THIS WEEK: • NETFLIX $NFLX • INTEL $INTC • UNITED AIRLINES $UAL • JOHNSON & JOHNSON $JNJ • PROCTER & GAMBLE $PG • GE AEROSPACE $GE • 3M $MMM • CHARLES SCHWAB $SCHW • INTERACTIVE BROKERS $IBKR • U.S. BANCORP $USB • CAPITAL ONE $COF • KINDER MORGAN $KMI • https://t.co/j8KIPGL1TV
Johnson & Johnson strikes deal with U.S. government to lower drug prices - CNBC
Johnson & Johnson halts mid-stage trial of experimental eczema drug - CNBC
Johnson & Johnson to buy Halda Therapeutics for $3.05B
573.46BUSD

See which Billionaires own this investment
Type
Common Stock
Exchange
NYSE
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
US4781601046
CUSIP
478160104
Sector
Healthcare
Industry
Drug Manufacturers - General
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
21.55
PEG Ratio
1.66
Book Value
33.87
Dividend Share
0
Dividend Yield
0.00%
Earnings Share
11.14
Wall Street Target Price
241.92
EPS Estimate Current Year
11.55
EPS Estimate Next Year
12.59
EPS Estimate Current Quarter
2.4647
EPS Estimate Next Quarter
2.7624
Most Recent Quarter
-
Revenue TTM
94,193,000,448
Gross Profit TTM
64,128,000,000
EBITDA
33,835,999,232
Profit Margin
28.46%
Return On Assets TTM
8.68%
Return On Equity TTM
35.03%
Revenue Per Share TTM
39.126
Qtly Revenue Growth YOY
9.10%
Diluted Eps TTM
11.14
Qtly Earnings Growth YOY
48.60%
Trailing PE
21.55
Forward PE
20
Price Sales TTM
6.1429
Price Book MRQ
7.0288
Enterprise Value Revenue
6
Enterprise Value EBITDA
14
51.01
0.63%154.07
0.36%925.00
0.23%156.48
0.00%418.50
0.00%387.10
-4.07%208.62
-0.81%203.29
-0.64%119.66
-0.25%350.20
-0.21%Curated watchlists where JNJ is featured.